Last reviewed · How we verify

NCT06789484: BABIES I

Characterization of the Gastrointestinal Microbiota in Newborn Infants

Recruiting now NA Last updated 13 April 2025
What this trial tests

NA trial testing Probiotic in Healthy Infants in 40 participants. Currently enrolling.

Timeline
4 March 2025
Primary endpoint
30 October 2025
31 December 2025

Quick facts

Lead sponsorHvidovre University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment40
Start date4 March 2025
Primary completion30 October 2025
Estimated completion31 December 2025
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Hvidovre University Hospital

Who can join

Under 1 Day, any sex, with Healthy Infants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The BABIES study is a single-center, randomized, double-blinded, placebo-controlled study in newborns with a 4-week intervention period from birth to 28 days of life followed by a 2-week follow-up period (Figure 1). The study will evaluate the seeding ability of supplementation with a probiotic strain. The aim is to investigate the recovery and engraftment of the probiotic strain in infant fecal samples after 4 weeks supplementation using a strain specific quantitative Polymerase Chain Reaction (qPCR).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Healthy Infants

Currently open trials in the same condition.

Other Hvidovre University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06789484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing